stella
beta
A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC — Stella
Recruiting
Back to Esophageal Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan
View full record on ClinicalTrials.gov